MEDP

MEDPACE HOLDINGS INC

MEDP·58506Q109·US·Common Stock·Healthcare - Diagnostics & Research-Activist

MEDP (MEDPACE HOLDINGS INC) is held by 234 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($1.3B), AQR CAPITAL MANAGEMENT LLC ($677.3M), VANGUARD PORTFOLIO MANAGEMENT LLC ($600.2M). Net institutional sentiment: Mixed. In Q2 2026, 2 members of Congress and 94 funds bought MEDP.

234
Holders
(21 Elite)
$9.7B
Total Value
38% (247)
Consensus
94 buying - 153 selling
13F: Insider & Congress: Updated regularly
MEDP

Smart Money Verdict

View all
Loading verdict
Held by 234 funds
21 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 28, 2026 · Activists Aug 14, 2026 · Congress May 28, 2026

InsiderTJTroendle August J.Sell $2.5MAug 26, 2026
InsiderKOKraft Robert O.Sell $2.4MAug 26, 2026
InsiderKOKraft Robert O.Exercise 4K shAug 26, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.5M(+1.1%)$1.3B0.0%+80.05%
32
Decreased
1.3M(-5.5%)$677.3M0.2%+45.10%
0
Increased
1.1M(+1.0%)$600.2M0.0%+32.83%
32
Increased
1M(+1.6%)$543.8M0.0%+32.74%
32
Increased
710,895(+4.2%)$376.5M0.0%+90.18%
32
Decreased
710,465(-4.7%)$376.3M0.0%+180.19%
0
Decreased
636,595(-17.8%)$337.1M2.2%+226.70%
0
Increased
579,241(+0.3%)$306.8M0.0%+81.75%
31
Decreased
473,211(-6.0%)$250.6M0.2%+86.81%
0
Increased
429,012(+8.4%)$227.2M0.1%+36.44%
40
Decreased
415,588(-17.6%)$220.1M0.3%+111.77%
0
Increased
397,500(+14.1%)$210.5M0.0%+131.60%
35
Increased
317,548(+10.1%)$168.2M0.0%+62.37%
34
Decreased
303,926(-10.7%)$161M0.0%+57.31%
0
Decreased
267,175(-40.1%)$141.5M1.0%+90.22%
0
Increased
266,547(+89.1%)$141.2M0.8%+30.70%
67
Increased
263,872(+98.3%)$139.7M0.1%+33.79%
58
Increased
250,781(+48.8%)$132.8M0.0%+23.68%
42
Decreased
234,537(-45.8%)$124.2M0.1%+58.48%
0
Increased
230,555(+213.0%)$122.1M0.3%+29.93%
58

Showing 1-20 of 257

1 / 13
MEDPMEDPMEDPACE HOLDINGS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used